Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors

Clinical trial NCT00227513 · COMPLETED

Trial details

NCT number: NCT00227513
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2005-07-01
Primary completion: 2010-06-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.